1. ホーム
  2. 一覧
論文 特許

論文 - 一覧

  • 14 Hits
  • 検索条件 : 絞込み (MeSH = Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics)
生物種 リソース名 タイトル
ヒト・動物細胞 Ba/F3(RCB0805) Novel Mechanism by a Bis-Pyridinium Fullerene Derivative to Induce Apoptosis by Enhancing the MEK-ERK Pathway in a Reactive Oxygen Species-Independent Manner in BCR-ABL-Positive Chronic Myeloid Leukemia-Derived K562 Cells.
ヒト・動物細胞 K562(RCB1897) KIR3DL1 Allotype-Dependent Modulation of NK Cell Immunity against Chronic Myeloid Leukemia.
ヒト・動物細胞 K562 Improved FRET Biosensor for the Measurement of BCR-ABL Activity in Chronic Myeloid Leukemia Cells.
ヒト・動物細胞 K562 TOPK is regulated by PP2A and BCR/ABL in leukemia and enhances cell proliferation.
ヒト・動物細胞 EoL-1 cell(RCB0641) miR-217 sensitizes chronic myelogenous leukemia cells to tyrosine kinase inhibitors by targeting pro-oncogenic anterior gradient 2.
遺伝子材料 pCAG-HIVgp (RDB04394) , pCMV-VSV-G-RSV-Rev (RDB04393) , CSII-EF-MCS (RDB04378). Generation of TCR-Expressing Innate Lymphoid-like Helper Cells that Induce Cytotoxic T Cell-Mediated Anti-leukemic Cell Response.
ヒト・動物細胞 KU812(RCB0495) Imatinib induces demethylation of miR-203 gene: an epigenetic mechanism of anti-tumor effect of imatinib.
ヒト・動物細胞 THP-1(RCB1189) Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1.
ヒト・動物細胞 Effect of arsenic trioxide on different cell lines derived from chronic myeloid leukemia.
ヒト・動物細胞 Differential responses of Bcl-2 family genes to etoposide in chronic myeloid leukemia K562 cells.
ヒト・動物細胞 KU812(RCB0495) , K562 Sorafenib induces apoptosis specifically in cells expressing BCR/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway.
ヒト・動物細胞 WEHI-3(RCB0035) Sensitivity of SNX2-ABL1 toward tyrosine kinase inhibitors distinct from that of BCR-ABL1.
実験動物マウス RBRC01071 Regulation of myeloid leukaemia by the cell-fate determinant Musashi.
ヒト・動物細胞 ILT-Mat(RCB0475) Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas.